2021
Building a Digital Health Risk Calculator for Older Women with Early-Stage Breast Cancer
Abujarad F, Wang S, Ulrich D, Mougalian S, Killelea B, Fraenkel L, Gross C, Evans S. Building a Digital Health Risk Calculator for Older Women with Early-Stage Breast Cancer. Lecture Notes In Computer Science 2021, 12780: 389-402. DOI: 10.1007/978-3-030-78224-5_27.Peer-Reviewed Original ResearchEarly-stage breast cancerOlder womenBreast cancerRadiation therapyTreatment therapiesEvidence-based treatment decisionsShared-decision modelRisk-benefit informationRisk calculatorRelative riskTreatment decisionsPatient healthDigital health toolsPatient comprehensionTherapyHealth toolsWomenCancerHealthPatientsClinicians
2019
Abandonment trajectories of conventionally fractionated adjuvant radiotherapy in breast cancer care.
Xu X, Soulos P, Herrin J, Wang S, Pollack C, Evans S, Gross C, Yu J. Abandonment trajectories of conventionally fractionated adjuvant radiotherapy in breast cancer care. Journal Of Clinical Oncology 2019, 37: 531-531. DOI: 10.1200/jco.2019.37.15_suppl.531.Peer-Reviewed Original ResearchPhysician peer groupsBreast cancer careAdjuvant radiotherapyCancer careHigher useNational Medicare claimsPatient risk factorsDistinct trajectoriesYears of ageLow useDifferent baseline levelsRisk-adjusted ratesPatient cohortRisk factorsBreast cancerCost implicationsMedicare claimsBaseline levelsRadiotherapyMedicare perspectiveCFRTCurve analysisPhysiciansPatientsLatent growth curve analysis
2016
A Biologically Effective Dose of ≥105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
Stahl J, Ross R, Harder E, Mancini B, Soulos P, Dosoretz A, Finkelstein S, Shafman T, Husain Z, Evans S, Yu J, Gross C, Decker R. A Biologically Effective Dose of ≥105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s174-s175. DOI: 10.1016/j.ijrobp.2016.06.438.Peer-Reviewed Original Research
2015
Adoption of Hypofractionated Whole-Breast Irradiation for Ductal Carcinoma In Situ Patients After Breast Conservation Surgery
An Y, Rutter C, Park H, Corso C, Mancini B, Lester-Coll N, Yeboa D, Evans S. Adoption of Hypofractionated Whole-Breast Irradiation for Ductal Carcinoma In Situ Patients After Breast Conservation Surgery. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e54-e55. DOI: 10.1016/j.ijrobp.2015.07.680.Peer-Reviewed Original Research
2013
Dosimetric and clinical predictors of the development of moist desquamation in breast cancer irradiation
Rutter C, Qin L, Higgins S, Moran M, Evans S. Dosimetric and clinical predictors of the development of moist desquamation in breast cancer irradiation. Journal Of Radiation Oncology 2013, 3: 147-152. DOI: 10.1007/s13566-013-0129-0.Peer-Reviewed Original ResearchMoist desquamationWhole breast radiotherapyAdjuvant whole breast radiotherapyLogistic regressionResultsTwenty-three patientsBreast cancer irradiationKaplan-Meier analysisImpact of patientLog-rank testMultivariate logistic regressionSignificant predictorsDose-volume relationshipClinical predictorsConsecutive patientsPatient factorsBreast radiotherapyGy fractionsCancer irradiationPatientsRadiotherapyBMIBreastTreatment factorsGyDesquamationEvidence-Based Cardiovascular Management of Patients Receiving Radiotherapy to the Heart
Taylor B, Evans S, Roberts K. Evidence-Based Cardiovascular Management of Patients Receiving Radiotherapy to the Heart. 2013, 409-420. DOI: 10.1007/978-1-4471-4441-0_28.ChaptersCardiovascular managementLong-term outcome studiesLate cardiovascular complicationsPrimary care physiciansEffect of radiotherapyRisks of radiotherapyCardiovascular complicationsCardiotoxic chemotherapyCare physiciansCardiovascular functionOutcome studiesCardiovascular teamRT planningRadiotherapyCardiovascular systemPatientsCancer therapyTherapy techniquesCell populationsAdverse changesChemotherapyHeartAdditive effectRiskTreatment